Collaboration accelerates quantum simulations by orders of magnitude, expanding global access to hybrid quantum computing and advancing the path toward industrial-scale quantum systems GPU-Accelerated QLEO Launch: QPerfect and Quobly unveil the next-generation QLEO emulator, powered by QPerfect's MIMIQ engine and fully compatible with NVIDIA CUDA-Q, delivering up to 100× faster quantum simulations. Bridging Quantum and Classical Systems: The collaboration expands access to hybrid quantum-classical computing, enabling developers and researchers to design, test, and scale quantum algorithms seamlessly across GPU and CPU environments.

Shares of the buy-now, pay-later provider have tumbled since its public trading debut in September.

Data demonstrate a favorable bioavailability profile of INM-901 oral formulation Data will support design and planning of first in human clinical trials Preparing for pre-IND meeting with the FDA Vancouver, British Columbia--(Newsfile Corp. - November 18, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company developing a pipeline of proprietary small-molecule drug candidates for diseases with high unmet medical needs, today announced the successful completion of pharmacokinetic ("PK") studies in large animal models for its Alzheimer's disease candidate INM-901. This marks the first preclinical study in which the oral formulation of INM-901 was administered in …

Webcast and Conference Call To be Held Tuesday, November 25, 2025, 8:30 am ET Webcast and Conference Call To be Held Tuesday, November 25, 2025, 8:30 am ET

ATLANTA--(BUSINESS WIRE)--Vestis (NYSE: VSTS), a leading provider of uniforms and workplace supplies, today announced that it will issue its fiscal fourth quarter and full year 2025 results after the market closes on Monday, December 1, 2025. A conference call will be held the following day, Tuesday, December 2, 2025 at 8:30 a.m. ET to review the Company's financial results and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will b.

The new ETF is designed to provide attractive monthly income while focusing on the long-term total return of common shares of JPMorgan Chase & Co. The new ETF is designed to provide attractive monthly income while focusing on the long-term total return of common shares of JPMorgan Chase & Co.

PHILADELPHIA and VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to announce that the Company will be presenting three clinical and one preclinical posters at the 2025 San Antonio Breast Cancer Symposium (SABCS®) taking place from December 9-12, 2025 at Henry B. Gonzalez Convention Center, 900 E. Market Street, San Antonio, Texas.

Joint offering seeks to embed trust and transparency into the lifecycle of tokenized assets, aligning sustainability metrics with the next generation of digital-market infrastructure. Joint offering seeks to embed trust and transparency into the lifecycle of tokenized assets, aligning sustainability metrics with the next generation of digital-market infrastructure.

The biggest thing impacting the EV maker's shares this week highlights its shift to being an AI play.

BCE Inc. is poised for a rebound after a significant dividend cut, improved cash flow, and a strategic U.S. expansion via Ziply Fiber. BCE now retains ~$500 million more quarterly, enabling debt reduction, balance sheet repair, and supporting a sustainable dividend yield. Valuation metrics show BCE trades below historical and peer averages, suggesting ~25% upside potential over the next 2-3 years, excluding organic growth.

First Patient Dosed at The Ohio State University Wexner Medical Center in this Multi-Center Trial Active component of HCW9302 is interleukin-2 -- cytokine that maintains proper numbers and functions of regulatory T cells to control excessive inflammation Gateway to development of a first-in-kind immunotherapeutic for autoimmune and pro-inflammatory diseases MIRAMAR, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to extend healthspan by targeting the link between chronic inflammation and disease, today announced the first patient was dosed at The Ohio …

Selection underscores QuickLogic's ability to deliver flexible, silicon-proven IP that reduces ASIC risk and shortens design cycles for commercial applications SAN JOSE, Calif. , Nov. 18, 2025 /PRNewswire/ -- QuickLogic Corporation (NASDAQ: QUIK), a developer of embedded FPGA (eFPGA) Hard IP and ruggedized FPGAs, announced today that its eFPGA Hard IP was selected by Chipus for a high performance data center production ASIC that will be fabricated on an industry-proven 12 nm process technology.

Investors still believe in tech. But it worries them as well.

Making its debut on 09/12/2016, smart beta exchange traded fund Fidelity Value Factor ETF (FVAL) provides investors broad exposure to the Style Box - Large Cap Value category of the market.

The First Trust Capital Strength ETF (FTCS) was launched on July 6, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Large Cap Blend segment of the US equity market.

The Invesco Equal Weight 0-30 Year Treasury ETF (GOVI) made its debut on 10/11/2007, and is a smart beta exchange traded fund that provides broad exposure to the Government Bond ETFs category of the market.

The Invesco QQQ (QQQ) was launched on March 10, 1999, and is a passively managed exchange traded fund designed to offer broad exposure to the Large Cap Growth segment of the US equity market.

The First Trust Mid Cap Growth AlphaDEX ETF (FNY) was launched on 04/19/2011, and is a smart beta exchange traded fund designed to offer broad exposure to the Style Box - Mid Cap Growth category of the market.

Designed to provide broad exposure to the Large Cap Growth segment of the US equity market, the iShares Top 20 U.S. Stocks ETF (TOPT) is a passively managed exchange traded fund launched on October 23, 2024.

Launched on January 27, 2004, the Vanguard Large-Cap ETF (VV) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Blend segment of the US equity market.